United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results
Go back to United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 549.90 +5.57 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $544.33 | 52 Week High | $164.04 | |||
| Open | $544.94 | 52 Week Low | $97.52 | |||
| Day High | $555.00 | P/E | 100.53 | |||
| Day Low | $544.06 | EPS | $5.47 | |||
| Volume | 377,592 | |||||
